Chemical & Engineering News – References comments made by David Roberts, professor of surgery and neurology, on a new optical coherence tomography (OCT) device that surgeons could potentially use to help remove tumors from the brain.
Post Tagged with: "cancer"
Drug Derived From Scorpion Venom Will Target Brain Cancer in Kids
Seattle Times – Quotes David Roberts, professor of surgery and neurology, on news that Seattle Children’s Hospital will be testing a new dye derived from scorpion venom that lights up cancer cells so surgeons can see — and remove — deadly brain tumors. Roberts and other colleagues have also been testing a similar drug compound, 5-aminolevulinic acid (5-ALA), which targets glial tumors.
Immunotherapy: the Big New Hope for Cancer Treatment
The Guardian – This article mentions Dartmouth’s Geisel School of Medicine in an article about the overall impact of a cancer immunotherapy clinical trial on melanoma patients, and that the two drugs used in the trial, ipilimumab and nivolumab, were created by the biotech firm called Medarex founded by immunologists from Geisel.
Obese Teenagers More Vulnerable to Food-Related Television Commercials
Gazette Review – A new study coming out of Dartmouth is showing that television food commercials are stimulating the brains of overweight teenagers more than any other group of people.
Early Use of Palliative Care in Cancer Improves Patients’ Lives, Outcomes for Caregivers
A new randomized clinical trial with Dartmouth investigators has noted significant improvement in several measures among those who began palliative care early.
Samir Soneji: Forecasting Population Health
In this Q&A, TDI demographer Samir Soneji, PhD discusses how demographers are able to predict how changes in population affect public policy by forecasting future disease and mortality rates.
Investigators Discover Mechanism Responsible for Tumor Invasion in Brain Cancer
A neuro-oncology research team at Dartmouth’s Norris Cotton Cancer Center, led by the Director Mark A. Israel, MD with first author Gilbert J. Rahme, PhD, recently identified the transcription factor Id4 as a suppressor of tumor cell invasion in glioblastoma.
Norris Cotton Cancer Center at Dartmouth Redesignated As NCI “Comprehensive Cancer Center”
The National Cancer Institute (NCI) has renewed its Cancer Center Support Grant to Norris Cotton Cancer Center (NCCC) at Dartmouth, continuing NCCC’s designation as a Comprehensive Cancer Center.
U.S. Spends More on Cancer Care, Saves Fewer Lives than Western Europe
Despite sharp increases in spending on cancer treatment, cancer mortality rates in the United States have decreased only modestly since 1970, Samir Soneji, PhD of Dartmouth’s Norris Cotton Cancer Center and The Dartmouth Institute for Health Policy & Clinical Practice has found.
Cherenkov Effect Improves Radiation Therapy for Patients with Cancer
Investigators from Dartmouth’s Norris Cotton Cancer Center published new findings about how the complex parts of the blue light known as the Cherenkov Effect can be measured and used in dosimetry to make radiation therapies safer and more effective.